After a rare jury trial between rival pharmaceutical companies, a federal jury on Wednesday rejected GlaxoSmithKline’s antitrust claims against Abbott Labs over an HIV drug’s dramatic price increase.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *